Davis Polk advised the book-running manager on an SEC-registered offering by Mohawk Capital Finance S.A. of floating-rate notes due 2020. The notes are fully and unconditionally…
Davis Polk is advising Williams on its $10.5 billion acquisition of all of the outstanding public common units of Williams Partners L.P. in an all stock-for-unit transaction at a 1.494…
Davis Polk advised the administrative agent and the lead arranger in connection with a $1.5 billion term facility and an amendment to The J.M. Smucker Company’s $1.75 billion revolving…
Davis Polk advised the joint book-running managers in connection with the offering by Canadian Pacific Railway Company of $500 million aggregate principal amount of 4.000% notes due…
Davis Polk advised the initial purchasers in connection with a $200 million Regulation S only high-yield offering by China Aoyuan Property Group Limited of its 7.50% senior notes due…
Davis Polk advised the representatives of the underwriters in connection with the SEC-registered offering of 17,250,000 shares of Class A common stock of Virtu Financial, Inc. for an…
Davis Polk advised the joint book-running managers and representatives of the underwriters in an SEC-registered offering by General Dynamics Corporation of $500 million aggregate…
Davis Polk acted as special product counsel to the representative of the several underwriters in connection with the SEC-registered offering of 5,750,000 shares (including 750,000…
Davis Polk, together with Slaughter and May, is advising Shire plc in connection with a recommended cash and stock offer for Shire’s entire share capital by Takeda Pharmaceutical Company…
Davis Polk advised the joint book-running managers and representatives of the underwriters in the approximately $42.2 million initial public offering by ASLAN Pharmaceuticals Limited…